Literature DB >> 6288364

Presence of corticotropin releasing factor-like immunoreactivity in hypophysial portal blood.

D M Gibbs, W Vale.   

Abstract

Hypophysial protal blood was collected from pentobarbital anesthetized male rats, and the content of corticotropin releasing factor-like immunoreactivity (CRF-LI) was measured using an RIA developed for synthetic ovine CRF. The concentration of CRF-LI in portal plasma was 104.9 +/- 9.7 pM. This concentration is in the range which has been shown to stimulate ACTH and beta-endorphin secretion in vitro. These data support the hypothesis that a molecule with the same or similar structure as synthetic ovine CRF is a physiologically significant hypothalamic releasing factor.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6288364     DOI： 10.1210/endo-111-4-1418

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


  22 in total

1.  Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.

Authors:  H M Schulte; G P Chrousos; P W Gold; J D Booth; E H Oldfield; G B Cutler; D L Loriaux
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

2.  Corticotropin-releasing hormone causes antidiuresis and antinatriuresis by stimulating vasopressin and inhibiting atrial natriuretic peptide release in male rats.

Authors:  J Gutkowska; M Jankowski; S Mukaddam-Daher; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Influence of acoustic stress by noise on gastrointestinal motility in dogs.

Authors:  M Gue; J Fioramonti; J Frexinos; M Alvinerie; L Bueno
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

4.  Isolation and amino acid sequence of corticotropin-releasing factor from pig hypothalami.

Authors:  M Patthy; J Horvath; M Mason-Garcia; B Szoke; D H Schlesinger; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

5.  Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.

Authors:  J P Liu; I J Clarke; J W Funder; D Engler
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Immunohistochemical identification of neurons containing corticotropin-releasing factor in the rat hypothalamus.

Authors:  M Kawata; K Hashimoto; J Takahara; Y Sano
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

7.  CRF-immunoreactive nerve fibers in the circumventricular organs of the monkey, Macaca fuscata.

Authors:  M Kawata; K Hashimoto; J Takahara; Y Sano
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

8.  Characterization of rat hypothalamic corticotropin-releasing factor.

Authors:  J Rivier; J Spiess; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

9.  Properties of rat anterior pituitary vasopressin receptors: relation to adenylate cyclase and the effect of corticotropin-releasing factor.

Authors:  R C Gaillard; P Schoenenberg; C A Favrod-Coune; A F Muller; J Marie; J Bockaert; S Jard
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 10.  Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress.

Authors:  Brent Myers; Jessica M McKlveen; James P Herman
Journal:  Front Neuroendocrinol       Date:  2013-12-18       Impact factor: 8.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.